English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduHusker engineer Eric Markvicka is developing a new approach for detecting acute exacerbations of chronic conditions.
Tag: Chronic Obstructive Pulmonary Disease
Cedars-Sinai Again Earns 5-Star Rating From Federal Agency
Cedars-Sinai Medical Center again has earned a five-star hospital rating from the Centers for Medicare & Medicaid Services (CMS)—the highest distinction from the federal agency.
Adults with chronic liver disease face more healthcare barriers than those with other diseases
UCLA researchers find that nearly 45% of adults with chronic liver disease encountered barriers to obtaining care compared with 34% of those with chronic obstructive pulmonary and/or cardiovascular disease, which are associated with a higher probability of recurrent acute care use…
Mount Sinai Experts to Present New Research on Long COVID, Lung Cancer, Asthma, Sleep Apnea, and More at ATS 2024 International Conference
Available for interview on breaking news, trending topics in respiratory medicine
Suspected bronchiectasis associated with higher risk of mortality in smokers
Bronchiectasis, a condition defined by widened lung airways, cough and sputum production, and frequent infections, often presents along with chronic obstructive pulmonary disease (COPD).
Inspiratory Capacity Important Marker for Disease Outcomes in COPD
Article title: Physiological predictors of morbidity and mortality in COPD: the relative importance of reduced inspiratory capacity and inspiratory muscle strength Authors: Devin B. Phillips, Matthew D. James, Conor D. O’Donnell, Sandra G. Vincent, Katherine A. Webb, Juan P. de-Torres,…
Peptide Treatment May Improve High White Blood Cell Count Associated with Smoking
Article title: Recombinant human β-defensin 2 delivery improves smoking-associated lung neutrophilia and bacterial exacerbation Authors: Nadia Milad, Marie Pineault, Gabrielle Bouffard, Michaël Maranda-Robitaille, Ariane Lechasseur, Marie-Josée Beaulieu, Sophie Aubin, Benjamin A. H. Jensen, Mathieu C. Morissette From the authors: This…
MedStar Washington Hospital Center Again Named Among Nation’s Top 50 for Heart Care
MedStar Washington Hospital Center has again achieved national ranking for Cardiology & Heart Surgery in the 2022-23 U.S. News & World Report “Best Hospitals” rankings. It moved up to No. 28, from No. 30 last year. It is the only nationally recognized heart program of its kind in the Washington metropolitan area. MedStar Washington also earned “high performing” ratings in cancer, gastroenterology & GI surgery, Urology, and in 12 common procedures and conditions.
World-first study reveals why people with COPD are more susceptible to COVID-19
Researchers from the Centenary Institute and the University of Technology Sydney have published the first study showing why people with chronic obstructive pulmonary disease (COPD) are at higher risk of developing severe COVID-19.
Researchers reverse emphysema in mice by injecting blood vessel wall cells
Researchers at Weill Cornell Medicine and NewYork-Presbyterian in New York have discovered that injecting mice with pulmonary endothelial cells—the cells that line the walls of blood vessels in the lung—can reverse the symptoms of emphysema. The study, which will be published July 21 in the Journal of Experimental Medicine (JEM), may lead to new treatments for chronic obstructive pulmonary disease (COPD), an inflammatory lung disease associated with smoking that is thought to be the third leading cause of death worldwide.
Blocking Cell Death Protein Reduces COPD-associated Inflammation, Lung Damage
Article title: Blockade of PD-1 decreases neutrophilic inflammation and lung damage in experimental COPD Authors Felix Ritzmann, Kai Borchardt, Giovanna Vella, Praneeth Chitirala, Adrian Angenendt, Christian Herr, Michael D. Menger, Markus Hoth, Annette Lis, Rainer M Bohle, Robert Bals, Christoph…
Nearly $500 million a year in Medicare costs goes to 7 services with no net health benefits
A UCLA-led study shows that physicians frequently order preventive medical services for adult Medicare beneficiaries that are considered unnecessary and of “low value” by the U.S. Preventive Services Task Force — at a cost of $478 million per year.
Amoeba Biology Reveals Potential Treatment Target for Lung Disease
In a series of experiments that began with amoebas — single-celled organisms that extend podlike appendages to move around — Johns Hopkins Medicine scientists say they have identified a genetic pathway that could be activated to help sweep out mucus from the lungs of people with chronic obstructive pulmonary disease a widespread lung ailment.
During pandemic, potentially avoidable hospitalizations for non-COVID conditions fell more among whites
New research suggests that the COVID-19 crisis has exacerbated existing racial health care disparities and that during the pandemic, African Americans may have had worse access than whites to outpatient care that could have helped prevent deterioration of their non–COVID-19 health conditions
Research News Tip Sheet: Story Ideas From Johns Hopkins Medicine
During the COVID-19 pandemic, Johns Hopkins Medicine Media Relations is focused on disseminating current, accurate and useful information to the public via the media. As part of that effort, we are distributing our “COVID-19 Tip Sheet: Story Ideas from Johns Hopkins” every other Tuesday.